The week in industry: Expansion of the European medicinal cannabis market

This week: Helsinn Healthcare (Lugano, Switzerland) lose in patent case, Canopy Growth Corporation (OT, Canada) continue progress in their production and distribution of medical-cannabis in the UK and Poland, and the US FDA allows uniQure to begin their Phase I/II study.